Cibus (NASDAQ:CBUS) stockholders approved all three proposals presented at the company’s 2026 annual meeting of stockholders, according to preliminary voting results announced during the virtual meeting.
Jason Stokes, the company’s corporate secretary, presided over the meeting on behalf of Mark Finn, chairman of the board. Stokes said the company held the meeting virtually “as we aim to increase access and participation.” Several members of Cibus’ board and management team attended, including Finn, Peter Beetham, a director and interim chief executive officer, and Carlo Broos, chief financial officer.
Stockholders Elect Board, Approve Executive Pay
Stockholders also approved, on an advisory basis, the compensation of Cibus’ named executive officers for the 2025 fiscal year.
The third proposal, ratifying the appointment of BDO USA, P.C. as the company’s independent registered public accounting firm for the year ending Dec. 31, 2026, was also approved. Representatives from BDO attended the meeting, according to Stokes.
Quorum Confirmed, Final Results to Be Filed
The board set April 6, 2026, as the record date for stockholders entitled to vote at the meeting. Stokes said notice of the meeting and proxy materials were first mailed to stockholders of record beginning April 20, 2026.
Christopher J. Woods of American Election Services served as inspector of elections. Stokes said Woods reported that holders of a majority in voting power of Cibus common stock issued and outstanding as of the record date were present virtually or by proxy, establishing a quorum.
The polls opened at 10:03 a.m. Pacific time on June 2, 2026, and closed at 10:07 a.m. Pacific time. Stokes said the results announced at the meeting were preliminary. Final voting results will be included in the inspector of elections’ report, reflected in the meeting minutes and filed with the Securities and Exchange Commission on Form 8-K within four business days of the meeting date.
No Stockholder Questions Addressed
After the formal business portion of the meeting was adjourned, Cibus opened a brief question-and-answer session. Stokes said the company had monitored questions submitted by stockholders before and during the meeting but had not received any questions “pertinent to the meeting.” As a result, no questions were answered during the session.
Stokes also noted that any responses during the Q&A could include forward-looking statements and referred investors to the company’s SEC filings for risk factors that could cause actual results to differ materially.
About Cibus (NASDAQ:CBUS)
Cibus, Inc is a biotechnology company specializing in precision gene editing for agricultural applications. Leveraging its proprietary Rapid Trait Development System (RTDS), Cibus develops improved crop traits without the introduction of foreign DNA. The company’s platform enables targeted modifications to plant genomes, allowing for enhanced disease resistance, herbicide tolerance and yield optimization in key row crops.
The company’s core business centers on trait development services and licensing partnerships.
